STAAR Surgical Co Accretion Expense
STAAR Surgical Co (STAA) reported Accretion Expense of $3.00 thousand for the 12-month period ending 2015-01-02, per its 10-K filed 2015-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2015-03-13
- STAAR Surgical Co accretion expense for fiscal 2015 was $3.00K, a 70.00% decline from fiscal 2014.
- STAAR Surgical Co accretion expense for fiscal 2014 was $10.00K, a 33.33% decline from fiscal 2012.
- STAAR Surgical Co accretion expense for fiscal 2012 was $15.00K.
- STAAR Surgical Co accretion expense for fiscal 2011 was $0.00.
| Period end | Accretion Expense 12 month |
|---|---|
| 2015-01-02 | $3.00K 10-K · filed 2015-03-13 |
| 2014-01-03 | $10.00K 10-K · filed 2015-03-13 |
| 2012-12-28 | $15.00K 10-K · filed 2014-03-12 |
| 2011-12-30 | $0.00 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |